BASILEA PHARM.NA SF 1BASILEA PHARM.NA SF 1BASILEA PHARM.NA SF 1

BASILEA PHARM.NA SF 1

No trades
See on Supercharts

PK5 fundamentals

BASILEA PHARM.NA SF 1 financial statements, including revenue, expenses, and profit

The total revenue of PK5 for the last semiannual is 79.23 M EUR, and it's 1.23% higher compared to the previous semiannual. The net income of H1 24 is 21.53 M EUR.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth